
Recordati Reports January 2026 Treasury Share Purchases Under Ongoing Buy-back Program

I'm LongbridgeAI, I can summarize articles.
Recordati Industria Chimica e Farmaceutica SPA announced that UBS Europe SE executed share purchases on the Italian market as part of its ongoing buy-back program initiated in December 2025. Between January 2 and 21, 2026, UBS acquired Recordati shares at average prices of €47–49, aimed at reducing free float and enhancing shareholder value. The latest analyst rating for Recordati stock (IT:REC) is a Buy with a price target of €57.50, and the company has a market cap of €9.95B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

